Plasma lipidomic analysis of stable and unstable coronary artery disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 31, Issue 11, 2011, Pages 2723-2732

  Meikle, Peter J ^a   Wong, Gerard ^a   Tsorotes, Despina ^a   Barlow, Christopher K ^a   Weir, Jacquelyn M ^a   Christopher, Michael J ^a   MacIntosh, Gemma L ^a   Goudey, Benjamin ^b,c   Stern, Linda ^c   Kowalczyk, Adam ^b   Haviv, Izhak ^a   White, Anthony J ^d   Dart, Anthony M ^d   Duffy, Stephen J ^d   Jennings, Garry L ^a   Kingwell, Bronwyn A ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b CSIRO   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ALFRED HOSPITAL   (Australia)

Author keywords

acute coronary syndromes; atherosclerosis; biomarker; lipids; risk factors

Indexed keywords

ALKYLPHOSPHATIDYLCHOLINE; CERAMIDE; CERAMIDE DIHEXOSIDE; CERAMIDE TRIHEXOSIDE; CHOLESTEROL; CHOLESTEROL ESTER; DIACYLGLYCEROL; GANGLIOSIDE GM3; LIPID; LYSOALKYLPHOSPHATIDYLETHANOLAMINE; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHATIDYLETHANOLAMINE; MONOHEXOSYLCERAMIDE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE PLASMALOGEN; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLINOSITOL; PLASMALOGEN ETHANOLAMINE; SPHINGOMYELIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID ANALYSIS; LIPIDOMICS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RISK ASSESSMENT; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGINA, STABLE; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; LIPIDS; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 80054901222     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.111.234096     Document Type: Article

References (16)

1. Blankenberg S, Zeller T, Saarela O, Havulinna AS, Kee F, Tunstall-Pedoe H, Kuulasmaa K, Yarnell J, Schnabel RB, Wild PS, Munzel TF, Lackner KJ, Tiret L, Evans A, Salomaa V. Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project. Circulation. 2010;121:2388-2397.
2. Schnabel RB, Schulz A, Messow CM, Lubos E, Wild PS, Zeller T, Sinning CR, Rupprecht HJ, Bickel C, Peetz D, Cambien F, Kempf T, Wollert KC, Benjamin EJ, Lackner KJ, Munzel TF, Tiret L, Vasan RS, Blankenberg S. Multiple marker approach to risk stratification in patients with stable coronary artery disease. Eur Heart J.
3. Falk E, Shah PK. Pathogenesis of atherothombosis. In: Fuster V, Topol EJ, Nabel EG, eds. Atherothrombosis and coronary artery disease. Philadelphia, PA: Lippincott Williams, Wilkins; 2005:451-465.
4. Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol. 2010;30: 1282-1292.
5. White AJ, Duffy SJ, Walton AS, Ng JF, Rice GE, Mukherjee S, Shaw JA, Jennings GL, Dart AM, Kingwell BA. Matrix metalloproteinase-3 and coronary remodelling: implications for unstable coronary disease. Cardiovasc Res. 2007;75:813-820. (Pubitemid 47238734)
6. Hamm CW, Braunwald E. A classification of unstable angina revisited. Circulation. 2000;102:118-122. (Pubitemid 30430562)
7. Dunstan DW, Zimmet PZ, Welborn TA, Cameron AJ, Shaw J, de Courten M, Jolley D, McCarty DJ. The Australian diabetes, obesity and lifestyle study (AusDiab): methods and response rates. Diabetes Res Clin Pract. 2002;57:119-129. (Pubitemid 34626451)
8. Kononenko I, Simec E, Robnik-Sikonja M. Overcoming the myopia of inductive learning algorithms with ReliefF. Applied Intelligence. 1997;7: 39-55. (Pubitemid 127508778)
9. Kira K, Rendell LA. A practical approach to feature selection. Proceedings of the Ninth International Workshop on Machine Learning. 1992;249-256.
10. Ford DA. Lipid oxidation by hypochlorous acid: chlorinated lipids in atherosclerosis and myocardial ischemia. Clin Lipidol. 2010;5:835-852.
11. Skaff O, Pattison DI, Davies MJ. The vinyl ether linkages of plasmalogens are favored targets for myeloperoxidase-derived oxidants: a kinetic study. Biochemistry. 2008;47:8237-8245.
12. Schmitz G, Ruebsaamen K. Metabolism and atherogenic disease association of lysophosphatidylcholine. Atherosclerosis. 2010;208:10-18.
13. Wilensky RL, Shi Y, Mohler ER III, Hamamdzic D, Burgert ME, Li J, Postle A, Fenning RS, Bollinger JG, Hoffman BE, Pelchovitz DJ, Yang J, Mirabile RC, Webb CL, Zhang L, Zhang P, Gelb MH, Walker MC, Zalewski A, Macphee CH. Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nat Med. 2008;14:1059-1066.
14. Croset M, Brossard N, Polette A, Lagarde M. Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem J. 2000; 345:61-67. (Pubitemid 30060104)
15. Wiesner P, Leidl K, Boettcher A, Schmitz G, Liebisch G. Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry. J Lipid Res. 2009;50:574-585.
16. Scherer M, Bottcher A, Schmitz G, Liebisch G. Sphingolipid profiling of human plasma and FPLC-separated lipoprotein fractions by hydrophilic interaction chromatography tandem mass spectrometry. Biochim Biophys Acta. 2011;1811:68-75.